Skin Manifestations in Patients with Chronic Renal Failure on Regular Hemodialysis

    January 1976 in “ PubMed ”
    S Griffon-Euvrard, Rosa Bustamante, J Thiovolet
    Image of study
    TLDR Patients on long-term hemodialysis often experience severe itching and various skin and nail problems.
    In 1976, S Griffon-Euvrard and colleagues studied skin disorders in 50 patients undergoing regular hemodialysis for chronic renal failure. The most common dermatological issue was pruritus (itching), which was particularly prevalent and severe in long-term dialysis patients. This was attributed to high urea blood concentration and secondary hyperparathyroidism. Other less frequent conditions included calcinosis cutis, hypermelanosis (found in 41% of the group), and nail disorders such as the absence of lunula (30%) and half and half nail (36%). Skin dryness (30%) and ichthyosis (10%) were also observed and could be related to pruritus. Alopecia, drug reactions, and prurigo had a specific incidence. Two patients presented bullous eruptions in sunlight-exposed skin areas, resembling Porphyria Cutanea Tarda, but with normal porphyrin levels in urine and feces.
    Discuss this study in the Community →

    Related Community Posts Join

    5 / 5 results

      community Don’t Get Too Hyped About PP405. We've Seen This Movie Before.

      in Research/Science  202 upvotes 6 days ago
      PP405 is a new hair loss treatment showing early promise with a 20% hair density increase, but skepticism exists due to past failures of similar treatments like Pyrilutamide, RU58841, and Bimatoprost. Users debate its potential effectiveness, with some hopeful due to Google's involvement, while others urge caution without more evidence.
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 10 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Topical finasteride now the safest possible path?

      in Finasteride/Dutasteride  84 upvotes 11 months ago
      Topical finasteride is considered a safer option for hair regrowth with fewer systemic side effects compared to oral finasteride. Some users report similar efficacy and side effects between topical and oral treatments, while others prefer topical due to reduced systemic exposure.

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  447 upvotes 2 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.

    Related Research

    1 / 1 results